Jun 08 - Jun 12, 2020
Join us on June 8-12 for the BIO International Convention, this year being in virtual event format!
E-meet CMO Stephen Eck moderating the panel How Will the Liquid Biopsy Market Realize Its $30B Potential? and engaging renowed leaders in the field in rewarding discussions:
Panel: How Will the Liquid Biopsy Market Realize Its $30B Potential?
Moderator: Stephen Eck, CMO Immatics US
Panelists: David Daly, CEO Thrive Detect ǀ Cindy Perettie, CEO Foundation Medicine ǀ Christopher Thibodeau, COO Immunis.AI ǀ Chorom Pak, CEO Lynx Biosciences
The liquid biopsy market is expected to grow to as much as $30 billion by 2025. Many factors are propelling the growth of the field in coming years, including the advantages of liquid biopsy over solid tumor biopsy, rising prevalence of cancer, increasing preference for non-invasive procedures, growing public and private funding to support research activities in the field of liquid biopsy and favorable government initiatives.
This panel includes advanced and emerging leaders in the field from public and private companies who will together discuss growth factors as well as how the field is overcoming clinical utility challenges, demonstrating sensitivity and specificity of liquid biopsy tests and establishing clarity in regard to reimbursement and regulation.
The recording is to be released on June 8. To access on-demand see here. We’re looking forward to e-hosting you!
Learn more about BIO Digital here.